Zusammenfassung
In meinem Beitrag “Biologische versus psychologische Perspektiven der Angststörungen” (s. oben) habe ich in Tabelle 1 eine Auflistung von Vorschlägen zur Ätiologie der Angststörungen und korrespondierender Behandlungen vorgelegt. Es wäre jedoch falsch, aus dieser Tabelle zu schlieβen, daβ die postulierten Ursachen zuerst entdeckt wurden und die Behandlungen als logische Deduktionen folgten. In vielen Fällen wurde eine Ursache aus den vermuteten Wirkmechanismen einiger Behandlungsformen erschlossen, von denen man glaubte, daβ sie gegen Angst wirksam seien. Die Behandlung psychischer Störungen schien stets mehr in der Realität begründet zu sein als deren Theorie. Es ist daher lehrreich, die Studien zum Behandlungserfolg von biologischen und psychologischen Behandlungsformen der Angststörungen zu untersuchen, die als erfolgreich betrachtet werden, um herauszufinden, wie stichhaltig die sachlichen Grundlagen dieser Schluβfolgerungen tatsächlich sind.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Agras WS, Teich MJ, Taylor CB, Roth WT, Brouillard ME (1990) Imipramine and exposure therapy in agoraphobia: untangling the actions and interactions, (in press)
Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Peknold JC, Rifkin A, Swinson RP (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiat 45:413–422
Clark DB, Taylor CB, Hayward C, King R, Roth WT, Agras WS (1991) Motor activity and tonic heart rate in panic disorder. Psychiat Res (in press)
Clark DB, Taylor CB, Roth WT, Agras WS (1990b) Surrepititious antianxiety medication use in a placebo controlled drug trial for panic disorder, (in press)
Cohen SD, Monteiro W, Marks IM (1984) Two-Year follow-up agoraphobics after exposure and imipramine. Br J Psychiat 144:276–281
Craske MG, Sanderson WC, Barlow DH (1987) How do desynchronous response systems relate to the treatment of agoraphobia: a follow-up evaluation. Behav Res Ther 25:117–122
Dilsaver SC, Coffnam JA (1989) Cholinergic hypothesis of depression: a reappraisal. J Clin Psychopharm 9:173–179
Fiegenbaum W (1988) Long-term efficacy of ungraded versus graded massed exposure in agoraphobics. In: I Hand, HU Wittchen (eds) Panic and Phobias. 2. Treatments and variables affecting course and outcome. Springer, Berlin Heidelberg New York Tokyo, pp 83–88
Fisher S, Greenberg RP (1989) A second opinion: rethinking the claims of biological psychiatry. In: Fisher S, Greenberg RP (eds) The limits of biological treatments for psychological distress. Comparisons with psychotherapy and placebo. Erlbaum, Hillsdale, NJ, pp 309–336
Frank JD (1961) Persuasion and Healing. A comparative study of psychotherapy. Johns Hopkins Press, Baltimore
Greenberg RP, Fisher S (1989) Examining antidepressant effectiveness: Findings, ambiguities, and some vexing puzzles. In: Fisher S, Greenberg RP (eds) The limits of biological treatments for psychological distress. Comparisons with psychotherapy and placebo. Erlbaum, Hillsdale, NJ, pp 1–37
Klein DF (1980) Anxiety reconceptualized. Compr Psychiat 21:411–427
Klein DF, Zitrin CM, Woerner MG, Ross DC (1983) Treatment of phobias. II. Behavior therapy and supportive psychotherapy: are there any specific ingredients? Arch Gen Psychiat 40:139–145.
Klerman GL, Ballenger JC, Burrows GD, DuPont RL, Noyes R, Pecknold JC, Rofkin A, Rubin RT, Swinson RP (1989) In reply [to Marks et al. (1989)]. Arch Gen Psychiat 46:670–672
Margraf J (1989) Beiträge zur Diagnostik, Theorie und Therapie des Paniksyndroms. Habilitationsschrift, Fachbereich Psychologie der Philipps-Universität Marburg
Margraf J, Ehlers A, Roth WT (1986a) Panic attacks: theoretical models and empirical evidence. In: Hand I, Wittchen HU (eds) Panic and phobias. Springer, Berlin Heidelberg New York Tokyo, pp 31–43
Margraf J, Ehlers A, Roth WT (1986b) Biological models of panic disorder and agoraphobia: a review. Behav Res Ther 24:553–567
Margraf J, Ehlers A, Roth WT (1986c) Sodium lactate infusions and panic attacks: a review and critique. Psychosom Med 48:23–51
Margraf J, Ehlers A, Roth WT (1988) Mitral valve prolapse and panic disorder, a review of their relationship. Psychosom Med 50:93–113
Marks IM (1987) Fears, phobias, and rituals. Panic, anxiety, and their disorders. Oxford University Press, Oxford
Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobena A, Tyrer P, Wittchen HU (1989) The ’efficacy’ of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Letter to the editor. Arch Gen Psychiat 46:668–670
Marks IM, Gray S, Cohen D, Hill R, Mawson D, Ramm E, Stem R (1983) Imipramine and brief therapist-aided exposure in agoraphobia having self-exposure homework. Arch Gen Psychiat 40:153–162
Mavissakalian Μ (1988) The mutually potentiating effects of imipramine and exposure in agoraphobia. In: Hand I, Wittchen HU (eds) Panic and phobias 2. Treatments and variables affecting course and outcome. Springer, Berlin Heidelberg New York Tokyo, pp 36–43
Mavissakalian M, Michelson L (1982) Agoraphobia: Behavioral and pharmacological treatments, preliminary outcome, and process findings. Psychopharm Bull 18:91–103
Mavissakalian M, Michelson L (1986) Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. J Clin Psychiat 143:1106–1112
Mavissakalian M, Michelson L, Dealy RS (1983) Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice. Br J Psychiat 143:348–355
Mellman TA, Uhde TW (1989) Electroencephalographic sleep in panic disorder. Arch Gen Psychiat 46:178–184
Overton DA (1966) State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacology 23:373–385
Pecknold JC, Swinson RP, Kuch K, Lewis CP (1988) Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. III. Discontinuation effects. Arch Gen Psychiat 45:429–436
Rachman S, Craske M, Tallman K, Solyom C (1986) Does escape behavior strengthen agoraphobic avoidance? A replication. Behav Ther 17:366–384
Teich MJ, Agras WS, Taylor CB, Roth WT, Gallen CC (1985) Combined pharmacological and behavioral treatment for agoraphobia. Behav Res Ther 23:325–335
Vermileya JA, Boice R, Barlow DH (1984) Rachman and Hodgson (1974) a decade later: how do desynchronous response systems relate to the treatment of agoraphobia. Behav Res Ther 22:615–621
Weissman MM, Klerman GL, Markowitz JS, Ouellette R (1989) Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 321:1209–1214
Zitrin CM, Klein DF, Woerner MG (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiat 37:63–72
Zitrin CM, Klein DG, Woemer MG, Ross DC (1983) Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiat 40:125–138
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Roth, W.T. (1992). Biologische versus psychologische Behandlung der Angststörungen. In: Fiegenbaum, W., Margraf, J., Florin, I., Ehlers, A. (eds) Zukunftsperspektiven der Klinischen Psychologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77073-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-77073-9_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-54774-7
Online ISBN: 978-3-642-77073-9
eBook Packages: Springer Book Archive